Clinical Trial: A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults >=18 to <65 Years of Age

U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864143) titled 'A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults >=18 to =18 to <65 years of age.

Study Start Date: March 05

Study Type: INTERVENTIONAL

Condition: Influenza SARS-CoV-2

Intervention: BIOLOGICAL: mRNA-1083 Composition 1 Dose A Lot A

Sterile liquid for injection

BIOLOGICAL: mRNA-1083 Composition 1 Dose A Lot B

Sterile liquid for injection

BIOLOGICAL: mRNA-1083 Composition 1 Dose B

Sterile liquid for injection

BIOLOGICAL: mRNA-1083 Composition 1 Dose C

Sterile liquid for injection

BIOLOGICAL: mRNA-1083 Composition 2 Dose A

Sterile liquid for injec...